Department Of Medicine
-
Allergists say alpha-gal red meat allergy better understood, as numbers continue to increase
Doctors at the Vanderbilt’s Asthma, Sinus and Allergy Program (ASAP) have continued to see an increase in the number of patients being treated for alpha-gal syndrome, commonly known as the red meat allergy, and with that increase has come more knowledge about management and treatment of the restrictive allergy. Read MoreDec 21, 2016
-
Research that ruled in 2016: Readers’ favorite stories
Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016. Read MoreDec 16, 2016
-
Protecting the blood-brain barrier
Vanderbilt investigators have discovered how a promising cancer immunotherapy causes brain swelling, findings that could lead to ways to protect brain function while fighting cancers. Read MoreDec 9, 2016
-
Making human beta cells reproduce
A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells. Read MoreDec 8, 2016
-
Study links lifestyle factors to formation of high-risk polyps
Lifestyle factors like cigarette smoking and red meat consumption are known to be associated with an increased risk of colon polyps that can lead to colorectal cancer. Read MoreDec 8, 2016
-
Building the basement membrane
Vanderbilt researchers have discovered steps in the regulation of a key enzyme that builds the basement membrane, a structure that undergirds nearly all animal tissues. Read MoreNov 21, 2016
-
Sarcoidosis research, patient care focus of newly created center
Vanderbilt University Medical Center (VUMC) has established a Sarcoidosis Center of Excellence under the direction of Wonder Drake, M.D., associate professor of Medicine and Pathology, Microbiology and Immunology. Read MoreNov 17, 2016
-
Max Planck Institute’s Fässler set for next Discovery Lecture
Reinhard Fässler, M.D., director of the Department of Molecular Medicine at the Max Planck Institute in Martinsried, Germany, will deliver the next Flexner Discovery Lecture on Nov. 10. Read MoreNov 3, 2016
-
Trial to test aortic valve technique in lower-risk patients
In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States. Read MoreOct 27, 2016
-
Study finds natural compound extends lifespan of worms
A compound found in buckwheat seeds extends the lifespan of worms, Vanderbilt investigators have discovered. Read MoreOct 20, 2016
-
Rheumatoid subtypes explored by PheWAS
A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis. Read MoreOct 7, 2016
-
Madhur lands NIH New Innovator Award
Meena Madhur, M.D., Ph.D., assistant professor of Medicine, has received an NIH New Innovator Award, which is designed to support exceptionally creative, early-career investigators who propose innovative, high-impact projects. Read MoreOct 6, 2016
-
BMI genotype and breast cancer risk
For breast cancer prevention, a new study provides evidence for lifestyle modification to reduce weight gain in adults. Read MoreSep 29, 2016
-
‘Shed-Meds’ to explore helping elderly reduce number of medications
Vanderbilt University Medical (VUMC) researchers have received a $2.9 million federal grant to test the effectiveness of a new intervention that aims to help older patients reduce the number of medications they may be taking on a regular basis. Read MoreSep 22, 2016
-
H. pylori and anemia – new evidence
The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide. Read MoreSep 22, 2016
-
Study explores anti-viral potential of existing drugs
Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read MoreSep 15, 2016
-
Going after the ‘heart attack gremlin’
A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target. Read MoreSep 8, 2016
-
VUMC mourns loss of Nephrology’s Schulman
Gerald Schulman, M.D., professor of Medicine, died Aug. 26. He was 65. Read MoreAug 30, 2016
-
Nervous system’s role in hypertension
Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease. Read MoreAug 29, 2016
-
It takes two to tango: beta cell development
Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read MoreJun 23, 2016